A0328: Differences in survival of clear cell metastatic renal cell carcinoma patients according to partial vs. radical nephrectomy

C. Cano Garcia, Frankfurt Am Main (DE)

Cano Garcia C. ¹, Flammia R.S.², Piccinelli M.¹, Panunzio A.¹, Tappero S.¹, Barletta F.¹, Incesu R-B.¹, Law K.¹, Tian Z.¹, Saad F.¹, Kapoor A.³, Shariat S.F.⁴, Tilki D.⁵, Briganti A.⁶, Terrone C.⁷, Antonelli A.⁸, De Cobelli O.⁹, Hoeh B.¹⁰, Kluth L.A.¹⁰, Chun F.K.H.¹⁰, Karakiewicz P.I.¹

¹University of Montréal Health Center, Cancer Prognostics and Health Outcomes Unit, Division of Urology, Montréal, Canada, ²Sapienza Rome University, Policlinico Umberto I Hospital, Dept. of Maternal-Child and Urological Sciences, Rome, Italy, ³McMaster University, Dept. of Urology, McMaster Institute of Urology, Hamilton, Canada, ⁴Medical University of Vienna, Dept. of Urology, Vienna, Austria, ⁵University Hospital Hamburg-Eppendorf, Martini-Klinik Prostate Cancer Center, Hamburg, Germany, ⁶IRCCS San Raffaele Scientific Institute; Vita-Salute San Raffaele University, Unit of Urology/Division of Oncology, Gianfranco Soldera Prostate Cancer Lab, Milan, Italy, ⁷IRCCS Policlinico San Martino, Dept. of Urology, Genoa, Italy, ⁸University of Verona, Azienda Ospedaliera Universitaria Integrata di Verona, Dept. of Urology, Verona, Italy, ⁹IEO European Institute of Oncology, IRCCS, Dept. of Urology, Milan, Italy, ¹⁰Goethe University Frankfurt, University Hospital Frankfurt, Dept. of Urology, Frankfurt, Germany